Clinical meaning of serum trimethylamine oxide, N-terminal-pro-brain natriuretic peptide, hypoxia-inducible factor-1α and left ventricular function and pregnancy outcome in patients with pregnancy-induced hypertension
Scindeks Asistent Scindeks Asistent — sistem za ozbiljne časopise i one koji to žele da postanu
PDF (engleski)

Sažetak

Purpose: To figure out the clinical meaning of serum trimethylamine oxide (TMAO), N-terminal-pro-brain natriuretic peptide (NT-proBNP) and hypoxia-inducible factor-1α (HIF-1α) with left ventricular function and pregnancy outcome in patients with pregnancy-induced hypertension.

Methods: From January 2018 to October 2020, taking 117 patients with gestational hypertension was as the research objects, assignation of them was into the gestational hypertension (pregnancy-induced hypertension group, 55 cases), mild preeclampsia (the mild PE, 43 cases) and severe preeclampsia (the severe PE, 19 cases) in the light of the severity of the disease. Analysis of the link of serum TMAO, NT-proBNP and HIF-1α with severity of disease and cardiac function indexes in patients with gestational hypertension was conducted; All patients were followed up to the end of pregnancy, and analysis of the predictive value of serum TMAO, NT-proBNP and HIF-1α on pregnancy outcome in patients was conducted.

Results:  The serum TMAO and NT-proBNP of patients were elevated, while HIF-1α was reduced with the severity of the disease (P < 0.05). The serum TMAO, NT-proBNP in patients with gestational hypertension were positively linked, but HIF-1α was negatively correlated with the severity of the disease (P < 0.05).  Left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV) were elevated in gestational hypertension patients, while ejection fraction (LVEF) was reduced with the severity of disease (P < 0.05). The serum TMAO, NT-probNP and HIF-1α were implicated in LVEDV, LVESV and LVEF values in patients with gestational hypertension (P < 0.05). The serum TMAO and NT-probNP in the poor pregnancy outcome were elevated vs. the good pregnancy outcome, but HIF-1α was reduced (P < 0.05). The AUC of the prediction of combined detection of serum TMAO, NT-probNP and HIF-1α on pregnancy outcome was greater vs. alone detection of each index (P < 0.05).

Conclusion: Serum TMAO, NT-proBNP and HIF-1α in patients with gestational hypertension are linked with disease severity and cardiac function, and have predictive and evaluative values for disease severity and pregnancy outcome.

Ključne reči

Array
Array
Array
Array
Array
Array
DOI: 10.5937/jomb0-37030

Reference

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Preuzimanja

Podaci o preuzimanju još nisu dostupni.